The disclosure relates to packages, and, more particularly, to wafer-scale packages including a power source and an electronic circuit.
The semiconductor and electronics industry uses material bonding techniques to bond different substrates together during semiconductor/circuit fabrication. Direct bonding is one type of bonding technique that is frequently used to bond different materials together. Direct bonding involves bonding different materials together without the aid of a specific bonding agent such as, for example, adhesive, wax, solder, or the like. Direct bonding techniques may be used to form component packages that house electrical components. A component package may be useful to protect the electrical components from different environmental conditions such as, e.g., pressure changes, moisture, bodily fluids, or the like.
In some examples, component packages may be placed in an oven after bringing the substrates of the component package in close contact to cause covalent bonds to form between the different substrates. Because this heating process included in forming a direct bond may involve heating the bond to an elevated temperature, temperature-sensitive components of the package may experience thermal damage when placed in a package that is subsequently sealed using direct bonding techniques. Moreover, because the process of forming a direct bond may involve one or more cycles of heating and cooling, mismatches between coefficients of thermal expansion for different substrates being bonded may cause warping and thermal stress fractures to develop between the different substrates. Warping and thermal stress fractures may weaken the bond between the different substrates and may reduce the hermeticity of a component package formed using direct bonding techniques.
A packaged device according to the present disclosure may be configured for implantation in a patient or external attachment to a patient. The packaged device includes at least two substrates that are hermetically bonded together such that the two substrates define an enclosed cavity between the two substrates. A control module may be disposed within the enclosed cavity that is configured to determine a physiological parameter of the patient and/or to provide electrical stimulation to the patient. An energy storage device, such as a battery, may be included within the enclosed cavity and may provide power to the control module.
The packaged device may be fabricated at low temperature from a variety of materials. In some examples, the packaged device may include semiconductor and/or insulating substrates (e.g., silicon and/or glass). The substrates may be bonded using a laser assisted bonding technique that maintains a relatively low temperature within the packaged device during bonding so that the components in the packaged device may not be thermally damaged. Additionally, the packaged device produced using the low temperature bonding technique may not incur stress fractures that may adversely affect the hermeticity of the package.
In one example according to the present disclosure, a medical device comprises a first substrate, a second substrate, a control module, and an energy storage device. The first substrate includes at least one of a first semiconductor material and a first insulating material. The second substrate includes at least one of a second semiconductor material and a second insulating material. The second substrate is bonded to the first substrate such that the first and second substrates define an enclosed cavity between the first and second substrates. The control module is disposed within the enclosed cavity. The control module is configured to at least one of determine a physiological parameter of a patient and deliver electrical stimulation to the patient. The energy storage device is disposed within the cavity and is configured to supply power to the control module.
In another example according to the present disclosure, a device comprises a first substrate, a second substrate, and a battery. The first substrate includes at least one of a first semiconductor material and a first insulating material. The first substrate includes a plurality of bonding pads. The second substrate includes at least one of a second semiconductor material and a second insulating material. The second substrate is bonded to the first substrate such that the first and second substrates define an enclosed cavity between the first and second substrates. The battery is housed in the enclosed cavity. The battery includes conductive contacts disposed on a bottom surface of the battery. The conductive contacts are connected (e.g., soldered) to two or more of the plurality of bonding pads such that the bottom surface of the battery faces the surface of the first substrate that includes the bonding pads.
In another example according to the present disclosure, a method comprises connecting a control module to one of a first substrate and a second substrate. The first substrate includes at least one of a first semiconductor material and a first insulating material. The second substrate includes at least one of a second semiconductor material and a second insulating material. The control module is configured to one of determine a physiological parameter of a patient and deliver electrical therapy to the patient. The method further comprises connecting an energy storage device to one of the first and second substrates and interfacing the first and second substrates such that the first and second substrates define an enclosed cavity between the first and second substrates. The enclosed cavity includes the control module and the energy storage device. Additionally, the method comprises heating an interface between the first and second substrates to form a bond between the first and second substrates.
The details of one or more examples are set forth in the accompanying drawings and the description below. Other features, objects, and advantages will be apparent from the description and drawings, and from the claims.
As described herein, a hermetically sealed packaged device includes various electronic components housed within a package fabricated using two substrates. In general, fabrication of the packaged devices includes attaching the various components to one of the substrates, then attaching the two substrates together such that the various components are housed within a cavity defined by the two substrates.
A packaged device of the present disclosure may include a variety of different electrical components. In one example, the packaged device may include one or more integrated circuits. Integrated circuits may be fabricated on one or more integrated circuit dice (e.g., silicon or glass) that are subsequently mounted in the packaged device. Additionally, or alternatively, the packaged device may include integrated circuits fabricated directly onto one or both of the substrates, e.g., embedded within or deposited onto the substrates.
The packaged device of the present disclosure may also include an energy storage device. In some examples, the energy storage device may include a battery (e.g., a solid state battery) and/or a capacitor. In examples where the energy storage device includes a battery, the battery may be fabricated as a discrete component and subsequently mounted within the packaged device. In other examples, the battery may be fabricated directly onto one or both of the substrates comprising the packaged device. In examples where the energy storage device includes a capacitor, the capacitor may be fabricated as a discrete component and subsequently mounted within the package or may be fabricated directly onto one or both of the substrates.
In some examples the packaged device may include a charging component that charges the energy storage device. By charging the energy storage device, the useful lifetime of the packaged device may be extended and the volume of the packaged device may be reduced. For example, when the energy storage device includes a battery, the volume of the battery may be reduced when a charging component is included in the packaged device since the battery may not be required to store an initial energy for the lifetime of the device, but may instead be recharged during the lifetime of the packaged device. The charging component may include a piezoelectric device, betavoltaic device, or a photovoltaic device, for example.
The packaged device of the present disclosure may include sensing components. For example, the packaged device may include a motion sensor (e.g., an inertial sensor) such as an accelerometer (e.g., one or more axis), and/or a gyroscopic sensor. Additionally or alternatively, the packaged device may include optical sensors that include an optical emitter and receiver that determine properties of the environment in which the packaged device is present. Additionally, or alternatively, the packaged device may include electrochemical sensors that interact with body tissues to sense the environment in which the packaged device is present. The sensing components, e.g., accelerometer, gyroscopic sensor, electrochemical sensor, and/or optical transceiver, may be fabricated directly onto one of the substrates that form the packaged device and/or may be fabricated on one or more dice that are subsequently mounted in the packaged device.
In some examples, the packaged device may include components used for communication with devices external to the packaged device. For example, the packaged device may include an antenna. The antenna may be fabricated on a die (e.g., glass or semiconductor) that is mounted within the package. Alternatively, or additionally, the antenna may be fabricated on one of the substrates of the packaged device. Alternatively, or additionally, the antenna may be fabricated as a wirewound coil and mounted on one of the substrates within the package.
In some examples, the packaged device may include passive components, e.g., integrated or discrete passive components, such as resistors, capacitors, inductors, etc. Additionally, or alternatively, in some examples the packaged device may include micro-electro-mechanical system (MEMS) components such as beams or diaphragms.
The packaged device may also include conductive traces that interconnect components included in the packaged device and that interface these components to devices external to the packaged device. For example, the packaged device may include one or more layers of conductive traces that are deposited on or within one or both substrates.
The packaged device may include one or more package vias that extend from an inside of the packaged device, through one or both of the substrates, to an outside surface of the packaged device. In one example, the packaged device may be designed for implantation into a patient as an implantable medical device, and the components of the packaged device may sense physiological electrical signals through the package vias and/or provide electrical therapy to a patient through the one or more of the vias. In other examples, the components of the packaged device may communicate using an intrabody communication (e.g., tissue conductance communication) to other devices located on or within the patient through the package vias.
In some examples, the packaged device may be implanted in a patient or attached externally to a patient. When the packaged device is configured to be implanted in the body of a patient, the packaged device may include an exterior coating that enhances biocompatibility of the packaged device for implantation, e.g., provides a greater biocompatibility than the materials used as the substrate of the packaged device (e.g., glass or silicon). For example, the exterior coating may include a titanium coating that covers the outside of the packaged device, excluding any electrodes that are external to the packaged device. In another example, the exterior coating may include a silicone layer that covers the outside of the packaged device, excluding any electrodes that are external to the packaged device.
The packaged device may include a variety of features depending on which components are included in the packaged device. The components (e.g., integrated circuits) of the packaged device may measure physiological parameters of a patient. For example, the components may measure physiological parameters of the patient using the accelerometer, gyroscopic sensor and optical transceiver. Additionally, or alternatively, the components may measure physiological parameters of the patient based on electrical signals received through the package vias. Additionally, or alternatively, the components of the packaged device may provide electrical stimulation (e.g., cardiac pacing and/or neurostimulation) through the package vias.
In some examples, the packaged device may not include package vias that extend from the inside of the packaged device to the outside surface of the packaged device. In these examples, the packaged device may include a sensor (e.g., temperature, pressure, accelerometer, gyroscopic sensor, and/or optical transceiver) that measures physiological parameters and a communication component which may communicate the data outside of the packaged device. For example, when the sensor is a motion sensor such as an accelerometer or a gyroscopic sensor, the packaged device may include electronic components that receive signals from the motion sensor and determine an orientation of the patient and/or an activity level of the patient based on the received signals. The communication device (e.g., including an antenna) may then transmit the physiological parameters (e.g., the orientation as determined based on an orientation of implant) determined by the electronic circuit to devices outside of the packaged device.
In examples when the packaged device includes package vias, components within the packaged device may include additional features. For example, the components may measure electrical physiological parameters of the patient in which the device is implanted or to which the device is connected externally. Electrical physiological parameters may include external electrocardiogram signals (ECG), internal electrocardiogram signals (IEGM), electroencephalogram signals (EEG), or other electrogram signals (e.g., electromyogram signals, gastric signals, peripheral neurological signals). Additionally, or alternatively, the components of the packaged device may provide electrical therapy to the patient, e.g., the components may provide neurostimulation and/or cardiac pacing functions through the package vias. Furthermore, when the packaged device includes a communication component, such as an antenna, the components of the packaged device may transmit data indicating the physiological parameters sensed by the packaged device. Additionally, or alternatively, components of the packaged device may communicate the physiological data to devices external to the packaged device using tissue conductance communication.
Although packaged device 100 of
Although packaged devices (e.g., packaged device 100, 114) of the present disclosure are illustrated as including a single cavity formed between two substrates, packaged devices of the present disclosure may include multiple cavities formed between multiple substrates bonded to a single supporting substrate. For example, a packaged device may include a single supporting substrate (e.g., planar substrate 102) and two capping substrates (e.g., recessed substrates 104) that are bonded together to form two separate cavities. In this example, a first cavity may be formed between the supporting substrate and a first capping substrate and a second cavity may be formed between the supporting substrate and a second capping substrate. The electrical components of the packaged device including two cavities may be included within the two separate cavities.
In some examples, packaged devices may be fabricated using a spacing substrate in order to increase a volume of the cavity of the packaged device. In these examples, components of a packaged device may be included on a supporting substrate, then a spacing substrate may be connected (e.g., around a perimeter of the components) to the supporting substrate. The spacing substrate may, for example, define a window that is configured to surround the components of the packaged device. Subsequently, a capping substrate may be placed over and connected to the spacing substrate such that the supporting substrate, spacing substrate, and capping substrate define a cavity in which the components are housed.
Planar substrate 102 and recessed substrate 104 may include a variety of materials. For example, planar and recessed substrates 102, 104 may include, but are not limited to, semiconductor materials and insulating materials. In some cases, planar substrate 102 and/or recessed substrate 104 may include silicon substrates and/or silicon carbide substrates. Planar substrate 102 and/or recessed substrate 104 may include glass substrates, such as borosilicate glass, sapphire, or fused silica. Although substrates 102, 104 of the present disclosure are described as including semiconductor and insulating materials, it is contemplated that other materials may be used as substrates 102, 104 of the present disclosure.
Planar substrate 102 and recessed substrate 104 of the packaged devices (e.g., 100, 114) may be fabricated from the same materials, or may be fabricated from different materials. In one example, planar and recessed substrates 102, 104 may both comprise glass substrates, e.g., be cut from a glass wafer (e.g., borosilicate glass). In this example, a plurality of packaged devices may be fabricated on a single glass wafer, then subsequently cut from the glass wafer to form individual packaged devices as illustrated in
The formation of the bond, illustrated as interface 112, between planar and recessed substrates 102, 104 may depend on the combination of materials from which planar and recessed substrates 102, 104 are selected. For example, two glass substrates may be bonded together when an interface layer (e.g., amorphous silicon) is added to one of the substrates 102, 104. In another example, two silicon substrates may be bonded together without an added interface layer. Example details regarding a method of bonding planar and recessed substrates 102, 104 are included in greater detail with respect to
Planar substrate 102 and recessed substrate 104 are bonded together such that planar substrate 102 and recessed substrate 104 define a cavity 116 within packaged device 100. Planar substrate 102 includes a surface 118 that defines a portion of cavity 116. Surface 118 may be referred to as interior surface 118 of planar substrate 102. A surface 120 of planar substrate 102 that is on an opposite side of interior surface 118 may form a portion of the outside surface of packaged device 100. Surface 120 may be referred to as an exterior surface 120 of planar substrate 102.
In some examples, packaged device 100 may be on the order of 0.75 millimeters to 3 millimeters thick, depending on the overall thickness of planar substrate 102, recessed substrate 104, and components included within cavity 116. For example, planar substrate 102 may have a thickness of approximately 200 micrometers or less, die 108 may have a thickness within a range of 100-150 micrometers or less, and ESD 106 may have a thickness on the order of 200 micrometers or greater. An area of packaged device 100 (e.g., a surface area of planar substrate 102) may be on the order of 10 to 50 mm2 resulting from widths in the range of 2 to 5 millimeters by lengths of 5 to 10 millimeters. Other example packaged devices according to the present disclosure may have dimensions that are greater or less than those described above. For example, a thickness of the packaged devices may be less than 0.75 millimeters or greater than 3 millimeters in some examples. Furthermore, a width and length of the packaged devices may be less than 2 millimeters or may be greater than 10 millimeters in some examples.
Planar substrate 102 may include bonding pads 122 on interior surface 118. Bonding pads 122 may include conductive material, e.g., metals, such as copper, aluminum, titanium, platinum, gold, and nickel. Components, such as ESD 106 and die 108, may be connected to bonding pads 122 using a solder material such as gold-tin or tin-lead. Individually deposited portions of solder material that form connections between components of packaged devices may be referred to as solder bumps 124. Bonding pads 122 may be electrically interconnected by conductive traces. For example, the conductive traces may be deposited as one or more layers on interior surface 118, or may be embedded (e.g. etched and deposited) in planar substrate 102. Example conductive traces that connect ESD 106 to die 108 are illustrated at 126. Conductive traces may include conductive material, e.g., metals, such as copper, aluminum, titanium, platinum, gold, nickel, or any other conductor suitable for electrically connecting components of packaged devices according to the present disclosure.
Although components may be attached to bonding pads 122 on interior surface 118 using solder bumps 124, components may be attached to bonding pads 122 using other methods. For example, components may be attached to bonding pads 122 using at least one of thermocompression stud bumping, conductive adhesives, anisotropically conductive films, tape automated bonding, and wire bonding.
In some examples, planar substrate 102 may include one or more external pads 128 deposited on exterior surface 120 of planar substrate 102. External pads 128 on exterior surface 120 may include conductive materials, e.g., metals, such as titanium, platinum, gold, niobium, or alloys of these materials. In some examples, when packaged device 100 is configured to be implanted in a patient, external pads 128 may include a biocompatible material such as titanium, platinum, gold, niobium, or alloys of these materials. Additionally, or alternatively, external pads 128 may include tantalum and/or alloys of tantalum.
In examples where planar substrate 102 includes external pads 128 on exterior surface 120 of planar substrate 102, planar substrate 102 may include package vias 130 that electrically connect bonding pads 122 and/or conductive traces on interior surface 118 to external pads 128 on exterior surface 120. In examples where planar substrate 102 includes a silicon substrate, package vias 130 may be formed using a through-silicon via formation process. In examples where planar substrate 102 includes glass (e.g., borosilicate float glass), package vias 130 may be formed using any conductive metal such as titanium, tungsten, copper, nickel, gold, platinum, and solders such as PbSn, AuSn, etc.
External pads 128 may generally be deposited along external surface 120 such that external pads 128 are nearly flush with external surface 120, e.g., external pads may be on the order of micrometers in thickness. In some examples, external pads 128 may receive electrical physiological signals such as ECG, IEGM, and EEG. Additionally, or alternatively, external pads 128 may provide electrical stimulation to a patient, such as cardiac pacing stimulation and/or neurostimulation. External pads 128 may also enable tissue conductance communication between components of packaged device 100 and devices external to packaged device 100. In some examples, package vias 130 may not terminate as external pads 128, but instead may be connected to leads 132-1, 132-2 as described herein with respect to
Various components may be included in packaged devices (e.g., packaged devices 100, 114) according to the present disclosure. For example, components may include analog/digital integrated circuits that provide signal conditioning functions (e.g., filtering and amplification), signal processing functions, logic functions. Integrated circuits may also include memory (e.g., volatile/non-volatile) that stores programs used by the integrated circuits to provide the functions associated with the integrated circuits described herein. Integrated circuits may also store measured physiological parameters in memory.
Integrated circuits included in packaged devices may be fabricated on one or more dice (e.g., die 108 of
In some examples, integrated circuits in packaged device 100 may monitor physiological parameters of a patient in which packaged device 100 is implanted, or to which packaged device 100 is attached. In some examples, integrated circuits in packaged device 100 may be configured to measure electrical physiological signals, such as ECG, IEGM, and EEG through package vias 130 using external pads 128 and/or leads 132-1, 132-2 that extend into the body of the patient.
In other examples, integrated circuits in packaged device 100 may be configured to determine impedance between external pads 128 and/or leads 132-1, 132-2 attached to packaged device 100. In one example, integrated circuits may measure impedance by applying a voltage between two of the external pads (or leads) and subsequently measuring a current generated in response to the applied voltage. The integrated circuit may then measure impedance to determine lead integrity. In another example, the integrated circuit may be used to measure nerve response with the device connected to a nerve cuff.
In other examples, integrated circuits in packaged device 100 may be configured to provide electrical therapy to the patient. For example, the integrated circuits may perform cardiac pacing and/or neurostimulation functions, depending on the application for which packaged device 100 is implanted.
Integrated circuits, and other components (e.g., sensors) included in packaged device 100 may receive power from ESD 106 included. Using the power provided by ESD 106, integrated circuits included in packaged device 100 may provide amplification functions, filtering functions, logic functions, and signal processing functions. In some examples, integrated circuits may provide electrical stimulation (e.g., cardiac pacing and/or neurostimulation) to the patient using power received from ESD 106. In other examples, integrated circuits may monitor electrical physiological signals of the patient using power received from ESD 106.
ESD 106 may include any suitable device that stores energy and that may be disposed within cavity 116. In one example, ESD 106 may include a battery, such as a solid state battery. In some examples, when ESD 106 includes a solid state battery, the solid state battery may include lithium phosphorous oxynitride (LiPON). Although a solid state battery may be used, in other examples, ESD 106 may include other types of battery structures and chemistries. For example, ESD 106 may include a thin film battery structure. In some examples, when ESD 106 includes a solid state battery, the solid state battery may not comprise a typical thin film structure. In some examples, ESD 106 may include a rechargeable battery. In other examples, ESD 106 may include a non-rechargeable battery.
ESD 106 may include ESD contacts 136 that provide a connection point for ESD 106 to other components of packaged device 100. When ESD 106 includes a solid state battery, ESD contacts 136 may be conductive contacts arranged along the bottom surface of the battery. The conductive contacts arranged on the solid state battery may be contacted using solder bumps 124, for example. Accordingly, when a solid state battery is included in packaged device 100 as ESD 106, the solid state battery may be configured to be connected to bonding pads 122 using solder bumps 124. The size of solder bumps 124 used to connect devices to planar substrate 102 may vary, as illustrated in
In some examples, ESD 106 may include a capacitor that stores charge for subsequent transfer to components of packaged device 100. When ESD 106 includes a capacitor, the capacitor may include contacts on a surface of the capacitor that may be connected to bonding pads 122 of planar substrate 102 using solder bumps 124.
In some examples, packaged device 100 may include a charging device that charges ESD 106 and therefore may prolong the lifetime of packaged device 100. The charging device may include a betavoltaic or photovoltaic device that generates electrical current that is received by ESD 106. The charging device may include a photovoltaic device in examples where packaged device 100 is externally fixed to the patient. In this case, one or both of planar and recessed substrates 102, 104 may be transparent to incident light (e.g., a borosilicate glass). In other examples, the charging device may include a piezoelectric generator, a radioisotope thermoelectric generator, a thermoelectric Peltier generator, or an inductive charging device (e.g., including an inductive coil).
The charging device may be included on a die that is mounted within package 100, such as die 108. In other examples, the charging device may be fabricated onto interior surface 118 of planar substrate 102, e.g., as an integrated device similar to integrated device 134 of
In some examples, packaged device 100 may include sensors such as an accelerometer or a gyroscopic sensor. Sensors included in packaged device 100 may receive power from ESD 106. Sensors, e.g., accelerometers and gyroscopic sensors, may be included in packaged devices as one or more dice (e.g., on die 108). Sensors may also be integrated onto one or both of planar and recessed substrates 102, 104 of packaged devices, e.g., as an integrated device similar to integrated device 134 of
Integrated circuits in packaged device 100 may be configured to determine various physiological parameters of the patient based on data received from the sensors. For example, integrated circuits may determine an orientation of the patient, and an activity level of the patient based on data received from motion sensors (e.g., accelerometer and gyroscopic sensors) included in the packaged device 100. In other examples, the integrated circuits may determine changes in metabolite levels in the blood, such as oxygen saturation levels or glucose levels, or changes in tissue perfusion based on data received from the optical transceiver component, when included in packaged device 100.
In some examples, packaged device 100 may include communication devices, such as antennas. When packaged device 100 includes an antenna, the antenna may be included on one or more dice mounted in packaged device 100 and/or on one or both of planar and recessed substrates 102, 104. In some examples, an antenna within packaged device 100 may communicate using telemetry protocols established by the medical industry. Integrated circuits included within packaged device 100 may transmit and receive data via the antenna included in packaged device 100. Data may include physiological parameters of the patient measured by sensors and physiological electrical signals measured through package vias 130.
Additionally, or alternatively, packaged device 100 may include a tissue conductance communication component (i.e., an interbody communication component) that communicates with devices external to packaged device 100 using tissue conductance communication. During tissue conductance communication, packaged device 100 may apply or receive voltage signals at external pads 128 or via leads 132 to communicate with external devices.
Bonding pads 122, conductive traces, and package vias 130 may be fabricated on a planar substrate 102 (200) as illustrated in
Die 108 may then be connected to bonding pads 122 on interior surface 118 of planar substrate 102 (202) as illustrated in
ESD 106 (i.e., ESD contacts 136) may then be connected to bonding pads 122 on interior surface 118 of planar substrate 102 (204) as illustrated in
Although ESD 106 is illustrated as straddling a single die 108 in
Recessed substrate 104 can be then placed over top of ESD 106 and die 108 so that recessed substrate 104 is in contact with planar substrate 102 (206) as illustrated in
An example method used to bond planar and recessed substrates 102, 104 is described in detail with respect to
Although the method illustrated and described with respect to
Although
The process of bonding (e.g., directly bonding) two or more substrates together to form a unified structure may include first preparing the contact surfaces of the substrates and then placing the substrates in contact with one another to establish a bond (e.g., direct bond) between the substrates (e.g., without an adhesive layer). Subsequently, the bond may be heated in order to strengthen the bond. In one example, a laser may be directed at the interface between the substrates in order to heat the interface and to strengthen the bond. Using a laser to heat the interface may provide a localized energy (e.g., localized in the region of the interface) that sufficiently heats the interface to promote bonding, but does not substantially heat the substrates, the cavity, and the components connected to the substrates. For example, when using a laser to heat the interface, the packaged device may be heated to no greater than 200° C. In some examples, using the laser to heat the interface may not result in a welding (e.g., melting and coalescing) of materials at the interface.
Potential thermal damage to components of packaged device 100 may depend on a temperature to which the components are heated and a length of time for which the components are heated. In some examples, when ESD 106 includes a solid state battery including LiPON, the solid state battery may be damaged if kept at approximately 180° C. or greater for an extended period of time (e.g., greater than a few minutes), but may not be damaged at solder reflow conditions such as when using SnPb at 220 ° C. for two minutes or less.
Therefore, when using a laser to heat the interface, the components (e.g., a solid state battery) connected to the substrates may not be heated to a temperature that may damage the components. This may be in contrast to a scenario where the bond is heated using other methods, such as anodic, fusion, or glass frit bonding. These processes (e.g., anodic, fusion, or glass frit bonding) may require temperatures ranging from 400 to 1100° C. and may result in the entire packaged device seeing these temperatures during bonding which may cause thermal damage to components. Accordingly, in some examples, components connected to the substrates may be thermally damaged when using heating methods other than laser heating. In some examples, when using laser enhanced bonding methods, the interface may be heated to greater temperatures (e.g., 400 to 1100° C.), but the rest of the packaged device may not since the heating may be localized at the point on which the laser is focused and since the substrates may not conduct heat to the portions of the packaged device outside of the laser heated region.
Furthermore, when substrates are used in a packaged device, the components connected to the substrates may be further insulated from laser heating of the interface since glass substrates may be thermally insulating. Therefore, a packaged device according to the present disclosure including glass substrates may include components that are thermally sensitive. Such components included in the packaged device may even be arranged near the interface on which the laser is directed during bonding without experiencing thermal damage. This may allow for more compact and flexible component layout options within the packaged device of the present disclosure relative to other available packaging options.
The surfaces of planar substrate 102 and recessed substrate 104 that are interfaced with one another may be referred to as “interface surfaces” of substrates 102, 104. The interface surface of planar substrate 102 may be a portion of interior surface 118 near the perimeter of planar substrate 102 where recessed substrate 104 is brought into contact with planar substrate. The interface surface of recessed substrate 104 may be the flattened surface of rim 138 of recessed substrate 104. In some examples, the flattened surface of rim 138 may not include interface layer 140, e.g., when one of the planar and recessed substrates 102, 104 include silicon substrates. In other examples, the flattened surface of rim 138 may include interface layer 140 (e.g., amorphous silicon) to promote bonding, e.g., when both planar and recessed substrates 102, 104 are glass substrates.
One or both of the interface surfaces may be prepared for direct bonding before placing the interface surfaces in contact with one another. Surface preparation may enable different atoms or molecules of the interface surfaces to attract one another. These attractive forces may create a direct bond between planar substrate 102 and recessed substrate 104. The type of surface preparation performed on the interface surfaces may vary, e.g., based on the chemical composition of substrates 102, 104.
One or both of the interface surfaces may be prepared by polishing to remove surface deformities such as burrs, gouges, ridges, or other irregularities (400). Different techniques may be used to polish the interface surfaces. For example, the interface surfaces may be mechanically polished, chemically polished, or treated by chemical-mechanical polishing (CMP) techniques. The interface surfaces may be polished until the surfaces exhibit comparatively low surface roughness values. Polishing the interface surfaces until the surfaces exhibit comparatively low surface roughness values may enhance direct bond formation. While smoother interface surfaces generally facilitate improved direct bond formation by allowing atoms or molecules of different surfaces to come into close contact, in some examples, comparatively rough surfaces may be bonded together.
In addition to or in lieu of polishing, the interface surfaces may be prepared for direct bonding by cleaning the interface surfaces to remove particles and contaminates from the interface surfaces (402). Cleaning the interface surfaces may include ultrasonic and/or megasonic cleaning. In addition to polishing and cleaning, interface surfaces may be prepared for direct bonding by chemically activating one or both of interface surfaces (404). Chemical activation may promote direct bond formation between the interface surfaces when the interface surfaces are brought into contact with one another. Chemical activation may involve exposing the interface surfaces to a plasma (e.g., nitrogen or oxygen plasma).
Independent of the specific techniques used, after suitably preparing the interface surfaces for direct bonding, the interface surfaces may be brought into contact with each other to establish a direct bond between substrates 102, 104 (406). Heating substrates 102, 104 may, in some examples, promote bond formation between the interface surfaces by providing energy to overcome an activation energy barrier for covalent bond formation (408). In some examples, a direct bond formed between interface surfaces may be optionally heated by directing a laser on at least a portion of the interface (410). The energy provided by the laser may heat the direct bond formed at the interface. Generally, a direct bond between the interface surfaces may hold substrates 102, 104 in a substantially fixed arrangement relative to one another. The direct bond formed between substrates 102, 104 that is heat treated, e.g., using a laser, may exhibit a greater strength than the bond formed prior to heating.
In one implementation of the method described in
In another implementation of the method described in
Packaged device 148 also differs from packaged device 100 in
In summary, when packaged device 148 is configured for a sensor application, example components included in packaged device 148 may include a sensor (e.g., a temperature sensor, accelerometer, gyroscopic sensor, and/or optical transceiver) fabricated on one of dice 142, 144, an antenna fabricated on dice 142, 144, and an integrated circuit fabricated on one of dice 142, 144. The integrated circuit may be configured to receive signals from the sensor, determine a physiological parameter of the patient (e.g., patient posture), and transmit the patient posture data to an external device via the antenna included in packaged device 148. Although not illustrated in
In
In example packaged device 162 of
With reference to
Although two external pads 128 and two leads 132-1, 132-2 are illustrated in
The number of external pads 128 and leads 132 may vary based on the application in which packaged device 172 is used. In examples where packaged device 172 is used for cardiac pacing, packaged device 172 may include one or more external pads 128 and leads 132. For example, an external pad 128 on packaged device 172 may serve as a reference electrode, while one or more leads 132 may serve as stimulation electrodes that deliver cardiac pacing stimulation to one or more chambers of the patient's heart.
In examples where packaged device 172 is used for neurostimulation, an external pad 128 on packaged device 172 may serve as a reference electrode, while one or more leads 132 may serve as neurostimulation electrodes that provide electrical therapy according to a program (e.g., including amplitude, pulse width, and pulse rate) stored within an integrated circuit of packaged device 172. In the case of neurostimulation, a plurality of leads, e.g., 8, 16, 24, or more leads may be used to provide stimulation. In some examples, the plurality of leads may be wrapped within separate sheaths that house the separate leads 132 and electrodes 178 and extend outward from packaged device 172 to a target stimulation location within the patient. In other examples, packaged device 172 may deliver leadless stimulation using a plurality of external pads 128 arranged on the exterior of packaged device 172 at a target stimulation site. Although 8, 16, 24, or more leads 132 may be used for neurostimulation applications, the number of external pads 128 and/or leads 132 may only be limited by the size of external pads 128 and/or leads 132, and the size of the substrate through which external pads 128 and leads 132 are attached.
As an alternative to coating packaged device 172 in encapsulation 174, packaged device 172 may be enclosed in a biocompatible package, such as a titanium sleeve. When enclosed in such a package, leads 132 may be fed through an opening in the package to the target stimulation site.
The functions attributed to the modules herein may be embodied as one or more processors, hardware, firmware, software, or any combination thereof. Depiction of different features as modules is intended to highlight different functional aspects and does not necessarily imply that such modules or units must be realized by separate hardware or software components. Rather, functionality associated with one or more modules may be performed by separate hardware or software components, or integrated within common or separate hardware or software components.
Modules of the packaged devices of
Each packaged device of
Control module 180 may represent any analog/digital circuit included in a packaged device that provides the functionality assigned to control module 180 herein. For example, control module 180 may represent an integrated circuit that is configured to provide analog electronic functions such as signal conditioning (e.g., filtering and amplification). Control module 180 may also represent an integrated circuit that provides logic functions and data storage functions. Control module 180 may be implemented on one or more dice included in a packaged device, and, additionally or alternatively, may be implemented as an integrated circuit fabricated on planar substrate 102.
Referring now to
Packaged device 191 of
Packaged devices may communicate with a programming device such as a handheld computing device, desktop computing device, or a networked computing device using an antenna and/or using tissue conductance communication. The programming device may be used by a clinician to program components of packaged devices, e.g., for cardiac electrical therapy and/or neurostimulation electrical therapy. Additionally, the packaged devices may upload measured physiological data to the programming device. In some examples, this disclosure contemplates a system that includes one or more of the packaged devices described herein and one or more programming devices to program components of packaged devices.
Referring now to
Referring now to
Referring now to
In some examples, electrical stimulation therapy may include neurostimulation therapy. In these examples, therapy/communication module 190, under control of control module 180, may provide neurostimulation therapy via external pads 128 and/or electrodes 178. Therapy/communication module 190 may deliver electrical stimulation therapy via one or more of leads 132 that include electrodes 178 implanted proximate to target locations associated with, for example, the brain, the spinal cord, pelvic nerves, peripheral nerves, or the gastrointestinal tract of a patient. Hence, stimulation provided by packaged device 199 may be used in different therapeutic applications, such as deep brain stimulation (DBS), spinal cord stimulation (SCS), pelvic stimulation, gastric stimulation, or peripheral nerve stimulation. Stimulation also may be used for muscle stimulation, e.g., functional electrical stimulation (FES), to promote muscle movement or prevent atrophy.
In other examples, packaged device 199 may provide functionality similar to that of an implantable pacemaker, or a cardioverter-defibrillator. In these examples, therapy/communication module 190, under control of control module 180, may provide cardiac sensing and pacing functions. In a cardiac electrical therapy application, leads 132 may extend into the heart of the patient and electrodes 178 may connect to the right ventricle of the heart, the left ventricle of the heart, and/or the right atrium of the heart. Using this electrode configuration, therapy/communication module 180 may sense electrical activity of the heart and/or deliver electrical stimulation (e.g., pacing pulses) to the heart using external pads 128 and/or electrodes 178 on leads 132.
Although packaged devices according to the present disclosure are described above for use in medical applications, the packaged devices of the present disclosure are not limited to medical applications, but instead it is contemplated that the packaged devices may also be used in general electronics applications. For example, the packaged devices may include integrated circuits, sensors, and other components that are not directed to medical applications, but are directed to general sensing applications, information processing applications (e.g., analog signal processing and digital information processing), and data storage applications (e.g., memory). In some medical or non-medical applications, the packaged devices may be mounted on other integrated devices (e.g., an integrated die) and packaged together with the integrated devices in a multi-chip package, or the packaged devices may be connected to a printed circuit board, for example.
Although the packaged devices according to the present disclosure are described as including the components on one of the two substrates that comprise the packaged devices, in some examples, both substrates of a packaged device according to the present disclosure may include components, such as sensors and integrated circuits, e.g., fabricated on dice connected to either substrate or fabricated directly on the substrates. In examples where both substrates include components, the components included on separate substrates may be electrically interconnected, for example, through the interface between the substrates.
Various examples have been described. These and other examples are within the scope of the following claims.
This application is related to U.S. application Ser. No. 13/016,253, entitled, “WAFER-SCALE PACKAGE INCLUDING POWER SOURCE,” now allowed, which claims the benefit of U.S. Provisional Application No. 61/406,961, entitled, “WAFER-SCALE PACKAGE INCLUDING POWER SOURCE,” and filed on Oct. 26, 2010, both of which are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3388301 | James | Jun 1968 | A |
3943557 | Frazee et al. | Mar 1976 | A |
4026304 | Levy | May 1977 | A |
4224565 | Sosniak et al. | Sep 1980 | A |
4285002 | Campbell | Aug 1981 | A |
4530029 | Beristain | Jul 1985 | A |
4645943 | Smith, Jr. | Feb 1987 | A |
4684884 | Soderlund | Aug 1987 | A |
4701826 | Mikkor | Oct 1987 | A |
4773972 | Mikkor | Sep 1988 | A |
4775831 | Annamalai | Oct 1988 | A |
4810318 | Haisma et al. | Mar 1989 | A |
4868712 | Woodman | Sep 1989 | A |
4870224 | Smith et al. | Sep 1989 | A |
4872844 | Grebe | Oct 1989 | A |
5008776 | Queyssac | Apr 1991 | A |
5054683 | Haisma et al. | Oct 1991 | A |
5059899 | Farnworth et al. | Oct 1991 | A |
5124508 | DuBrucq | Jun 1992 | A |
5144946 | Weinberg | Sep 1992 | A |
5196374 | Hundt | Mar 1993 | A |
5315486 | Fillion et al. | May 1994 | A |
5381039 | Morrison | Jan 1995 | A |
5381804 | Shambroom | Jan 1995 | A |
5403782 | Dixon | Apr 1995 | A |
5489321 | Tracy et al. | Feb 1996 | A |
5528463 | McLellan | Jun 1996 | A |
5572065 | Burns | Nov 1996 | A |
5592391 | Muyshondt et al. | Jan 1997 | A |
5606264 | Licari et al. | Feb 1997 | A |
5647932 | Taguchi et al. | Jul 1997 | A |
5682065 | Farnworth et al. | Oct 1997 | A |
5693111 | Kadowaki et al. | Dec 1997 | A |
5724728 | Bond | Mar 1998 | A |
5837562 | Cho | Nov 1998 | A |
5938956 | Hembree et al. | Aug 1999 | A |
5955789 | Vendramin | Sep 1999 | A |
6020634 | Gerber | Feb 2000 | A |
6022787 | Ma | Feb 2000 | A |
6032064 | Devlin et al. | Feb 2000 | A |
6074891 | Staller | Jun 2000 | A |
6144866 | Miesel et al. | Nov 2000 | A |
6145384 | Ikeda et al. | Nov 2000 | A |
6171252 | Roberts | Jan 2001 | B1 |
6221024 | Miesel | Apr 2001 | B1 |
6278379 | Allen et al. | Aug 2001 | B1 |
6287256 | Park et al. | Sep 2001 | B1 |
6297072 | Tilmans et al. | Oct 2001 | B1 |
6297551 | Dudderar et al. | Oct 2001 | B1 |
6298255 | Cordero et al. | Oct 2001 | B1 |
6303977 | Schroen et al. | Oct 2001 | B1 |
6323550 | Martin et al. | Nov 2001 | B1 |
6335669 | Miyazaki et al. | Jan 2002 | B1 |
6343019 | Jiang et al. | Jan 2002 | B1 |
6394953 | Devlin et al. | May 2002 | B1 |
6477901 | Tadigadapa et al. | Nov 2002 | B1 |
6486534 | Sridharan et al. | Nov 2002 | B1 |
6500694 | Enquist | Dec 2002 | B1 |
6514798 | Farnworth | Feb 2003 | B2 |
6515870 | Skinner et al. | Feb 2003 | B1 |
6516808 | Schulman | Feb 2003 | B2 |
6555025 | Krupetsky et al. | Apr 2003 | B1 |
6555856 | Staller | Apr 2003 | B1 |
6563133 | Tong | May 2003 | B1 |
6566596 | Askew | May 2003 | B1 |
6566736 | Ogawa et al. | May 2003 | B1 |
6638784 | Bartlett et al. | Oct 2003 | B2 |
6696369 | Fraser et al. | Feb 2004 | B2 |
6718206 | Casavant | Apr 2004 | B2 |
6762072 | Lutz | Jul 2004 | B2 |
6774327 | Wong | Aug 2004 | B1 |
6821342 | Mattes et al. | Nov 2004 | B2 |
6822326 | Enquist et al. | Nov 2004 | B2 |
6855115 | Fonseca et al. | Feb 2005 | B2 |
6867073 | Enquist | Mar 2005 | B1 |
6874367 | Jakobsen | Apr 2005 | B2 |
6902987 | Tong et al. | Jun 2005 | B1 |
6903918 | Brennan | Jun 2005 | B1 |
6962835 | Tong et al. | Nov 2005 | B2 |
6968743 | Rich et al. | Nov 2005 | B2 |
6986965 | Jenson et al. | Jan 2006 | B2 |
7041178 | Tong et al. | May 2006 | B2 |
7078726 | Pichler et al. | Jul 2006 | B2 |
7096580 | Gonzalez et al. | Aug 2006 | B2 |
7109092 | Tong | Sep 2006 | B2 |
7126212 | Enquist et al. | Oct 2006 | B2 |
7147604 | Allen et al. | Dec 2006 | B1 |
7150195 | Jacobsen et al. | Dec 2006 | B2 |
7162926 | Guziak et al. | Jan 2007 | B1 |
7205181 | MacIntyre | Apr 2007 | B1 |
7230321 | McCain | Jun 2007 | B2 |
7233048 | Rybnicek | Jun 2007 | B2 |
7238999 | LaFond et al. | Jul 2007 | B2 |
7247517 | Rumer et al. | Jul 2007 | B2 |
7305889 | Fortin et al. | Dec 2007 | B2 |
7318264 | Schugt | Jan 2008 | B2 |
7396698 | Horning et al. | Jul 2008 | B2 |
7403818 | Kramer et al. | Jul 2008 | B2 |
7417307 | Haluzak et al. | Aug 2008 | B2 |
7462552 | Tong et al. | Dec 2008 | B2 |
7485968 | Enquist et al. | Feb 2009 | B2 |
7495462 | Hua et al. | Feb 2009 | B2 |
7540188 | Wiese et al. | Jun 2009 | B2 |
7540934 | Hofmann et al. | Jun 2009 | B2 |
7553582 | Bates | Jun 2009 | B2 |
7563692 | Fortin et al. | Jul 2009 | B2 |
7622324 | Enquist et al. | Nov 2009 | B2 |
7647836 | O'Brien et al. | Jan 2010 | B2 |
7748277 | O'Brien et al. | Jul 2010 | B2 |
7759774 | Fraser et al. | Jul 2010 | B2 |
7781250 | Wang et al. | Aug 2010 | B2 |
7829363 | You | Nov 2010 | B2 |
7886608 | Mothilal et al. | Feb 2011 | B2 |
7902851 | Fenner et al. | Mar 2011 | B2 |
8072056 | Mueller et al. | Dec 2011 | B2 |
8125146 | Park | Feb 2012 | B2 |
8448468 | Pastel et al. | May 2013 | B2 |
8766435 | Hundt | Jul 2014 | B2 |
20010033024 | Fraser et al. | Oct 2001 | A1 |
20020115920 | Rich et al. | Aug 2002 | A1 |
20040012083 | Farrell et al. | Jan 2004 | A1 |
20040079277 | Mattes et al. | Apr 2004 | A1 |
20040082145 | Reichenbach et al. | Apr 2004 | A1 |
20040186396 | Roy et al. | Sep 2004 | A1 |
20040222478 | Zhang et al. | Nov 2004 | A1 |
20050009246 | Enquist et al. | Jan 2005 | A1 |
20050065565 | Kramer et al. | Mar 2005 | A1 |
20050151151 | Hawtof et al. | Jul 2005 | A1 |
20050284815 | Sparks et al. | Dec 2005 | A1 |
20060033204 | Fraser et al. | Feb 2006 | A1 |
20060110854 | Horning et al. | May 2006 | A1 |
20060264004 | Tong et al. | Nov 2006 | A1 |
20060267167 | McCain | Nov 2006 | A1 |
20060273430 | Hua et al. | Dec 2006 | A1 |
20070037379 | Enquist et al. | Feb 2007 | A1 |
20070107524 | O'Brien et al. | May 2007 | A1 |
20070158769 | You | Jul 2007 | A1 |
20070170839 | Choi et al. | Jul 2007 | A1 |
20070179545 | Warkentin et al. | Aug 2007 | A1 |
20070199385 | O'Brien et al. | Aug 2007 | A1 |
20070251338 | Wiese et al. | Nov 2007 | A1 |
20070261497 | O'Brien et al. | Nov 2007 | A1 |
20070269921 | You | Nov 2007 | A1 |
20080027332 | Bradley | Jan 2008 | A1 |
20080102096 | Molin et al. | May 2008 | A1 |
20080312726 | Frank et al. | Dec 2008 | A1 |
20090057868 | Wang et al. | Mar 2009 | A1 |
20090270707 | Alfoqaha et al. | Oct 2009 | A1 |
20090308169 | Mothilal et al. | Dec 2009 | A1 |
20100262208 | Parker | Oct 2010 | A1 |
20100263794 | George et al. | Oct 2010 | A1 |
20100304151 | Tuennermann et al. | Dec 2010 | A1 |
20100314149 | Gerrish et al. | Dec 2010 | A1 |
20100314726 | Mueller et al. | Dec 2010 | A1 |
20100314733 | Mueller et al. | Dec 2010 | A1 |
20100315110 | Fenner et al. | Dec 2010 | A1 |
20100324614 | Mattes et al. | Dec 2010 | A1 |
20120064670 | Mueller et al. | Mar 2012 | A1 |
20120100318 | Danzl et al. | Apr 2012 | A1 |
20120161305 | Ruben et al. | Jun 2012 | A1 |
20120197155 | Mattes et al. | Aug 2012 | A1 |
Number | Date | Country |
---|---|---|
0232935 | Aug 1987 | EP |
1128174 | Aug 2001 | EP |
1864784 | Dec 2007 | EP |
2008044349 | Apr 2008 | WO |
2010117382 | Oct 2010 | WO |
Entry |
---|
Chinese Office Action, application No. 201180051580.1, mailed Mar. 16, 2015, 15 pages, English translation. |
Chinese Office Action, application No. 201180051580.1, mailed Mar. 16, 2015, 15 pages, 7 pages. |
Final Office Action from U.S. Appl. No. 12/912,433 dated Sep. 24, 2013 “Laser Assisted Direct Bonding”, 17 pages. |
Wiemer et al., “Developments trends in the field of wafer bonding technologies,” 214th ECS Meeting, Abstract #2229, Oct. 12-Oct. 17, 2008, Honolulu, HI (1 p.). |
Sari et al., “Applications of laser transmission processes for the joining of plastics, silicon and glass micro parts,” Microsyst Technol (2008) 14: 1879-1886, published online Jul. 18, 2008. |
Theppakuttai et al., “Localized Laser Transmission Bonding for Microsystem Fabrication and Packaging,” Journal of Manufacturing Processes, vol. 6, No. 1, 2004 (8 pp). |
Wild et al., “Locally selective bonding of silicon and glass with laser,” Sensors and Actuators A: Physical, vol. 93, Issue 1, Aug. 25, 2001, p. 63-69. |
Park, “Characterization of transmission laser bonding (TLB) technique for microsystem packaging,” Arizona State University, May 2006 (135 pp.). |
EnerChip CBC012, Rechargeable Solid State Energy Storage: 12μAh, 3.8V, Cymbet Corporation, DS-72-02 Rev A, 2009-2010 Cymbet™ Corporation (5 pp.). |
Thinergy, The Leading Thin Power Solution, 2010 Infinite Power Solutions, Inc. (2 pp.), accessed online Oct. 14, 2010 at http://www.infinitepowersolutions.com/product/thinergy. |
Office Action from co-pending U.S. Appl. No. 12/912,433 dated Mar. 14, 2013 (14 pages). |
Office Action from related U.S. Appl. No. 12/977,890 dated Dec. 31, 2012 (17 pages). |
Lau, “MEMS Structures for Stress Measurements for Thin Films Deposited Using CVD”, Master of Science Thesis, Massachusetts Institute of Technology, Feb. 2001, 79 pages. |
Lea et al., “DRIE from MEMS to wafer-level packaging”, Solid State Technology, Dec. 2007; 50 (12) 8 pages. Retrieved online on Oct. 11, 2010. Available online at url:http://www.electroiq.com/ElectroIQ/en-us/index/display/Eemiconductor—Article—Tools—Template.articles.solid-state-technology.volume-50.issue-12.features.mems.drie-from-mems-to-wafer-level-packaging.html. |
Oberg et al., Machinery's Handbook, 25th edition, Industrial Press, New York, NY, 1996: title page, copyright page and p. 267, 2 pages. |
Osterberg et al., “M-TEST: A Test Chip for MEMS Using Electostatically Actuated Test Structures”, Journal of Microelectromechanic Systems, Jun. 1997; 6(2): pp. 107-118. |
Pham et al., “High-aspect-ratio bulk micromachined vias contacts, ” ProcSAFE and Prorisc 2004, Veldhoven, NL, Nov. 25-26, 2004, pp. 742-746. |
Potkay, “Long Term, Implantable Blood Pressure Monitoring Systems”, Biomed Microdevices, 2008; 10:379-392. Published online Dec. 20, 2007. |
Amendment from U.S. Appl. No. 12/912,433, filed Jun. 7, 2013 (13 pages). |
Office Action from U.S. Appl. No. 12/977,890 dated Jun. 5, 2013 (19 pages). |
Brown, “Precision Laser Welding of Clear Thermoplastics Without Additives”, Medical Design Technology, Aug. 5, 2013, 7 pages. Located on the World Wide Web at http://www.mdtmag.com/articles/2013/08/precision-laser-welding-clear-thermoplastics-without-additives. |
Response to Office Action dated Sep. 24, 2013, from U.S. Appl. No. 12/912,433, filed Nov. 12, 2013, 14 pp. |
International Search Report and Written Opinion of PCT/US2011/033986, dated Feb. 10, 2012, 11 pp. |
Gillner et al, “Laser Bonding of Micro Optical Components”, Proceedings of SPIE, vol. 4941, pp. 112-120, Oct. 30, 2003. |
Witte et al., “Laser Joining of Glass with Silicon”, Proceedings of SPIE, vol. 4637, Jan. 21, 2002, pp. 487-495. |
Number | Date | Country | |
---|---|---|---|
20140171822 A1 | Jun 2014 | US |
Number | Date | Country | |
---|---|---|---|
61406961 | Oct 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13016253 | Jan 2011 | US |
Child | 14186039 | US |